Aster Capital Management (Difc) LTD Vaxcyte, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 4,173 shares of PCVX stock, worth $386,753. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,173Holding current value
$386,753% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
348Shares Held
123MCall Options Held
748KPut Options Held
411K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.06 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$1.01 Billion0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$921 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$805 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$454 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.5B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...